Caffeine & Anxiety: Effects & Evidence—what is actually supported

Caffeine can increase alertness—and in some people, that same mechanism can worsen sleep and recovery. This detour (worse sleep → more tension the next day) can subjectively feel like “anxiety from caffeine.” The evidence, however, is not uniform: robust data with anxiety as a primary, clinically measurable outcome are limited.

First the levers: Sleep, light, movement—why anxiety plays along indirectly

If you suspect anxiety from caffeine, the most common realistic explanation is not necessarily a direct “anxiety programming,” but an indirect chain: caffeine affects sleep, and less sleep/recovery can weaken the emotional regulation mechanisms the next day. That can feel like more anxiety, tension, or rumination.

Why this is plausible: Multiple research lines on caffeine focus on sleep parameters (sleep architecture, EEG, sleep quality) and on timing/dose (how strongly caffeine still acts later). The systematic mechanistic review on EEG parameters provides biological plausibility because it explicitly examines caffeine’s effects on sleep-related EEG signals (Chmiel et al., 2026, PMID 42075032). This does not automatically mean “anxiety always increases,” but it supports the intermediate step through sleep.

Practically: If you are sensitive in the evening, “supplementing against anxiety” is often the wrong first order. A better next step is to take caffeine as early as possible, rather than addressing anxiety directly. The RCT approach to dose and timing supports exactly this logic: dose and timing effects can be relevant for what happens in the subsequent night (Gardiner et al., 2025, PMID 39377163).

You should also check your sleep routine and daylight exposure when you reduce or remove caffeine in the evening: daylight and circadian rhythm are likewise major drivers for sleep and for how the body adapts. If you want to read more: Circadian rhythm: effects & evidence (what is supported).

Movement during the day can lower excitability and stabilize sleep—so a potential caffeine side effect may be indirectly buffered. The RCTs mentioned below primarily address caffeine/sleep measurements or performance, but as a lifestyle lever, movement still makes sense because it rarely “creates anxiety.” Instead, it typically supports sleep and recovery. If you want, you can further align the caffeine strategy (timing) with your activity pattern—often that is more effective than adding extra substances.

What the studies on “caffeine and anxiety” actually measure (and what they don’t)

The most important direct answer upfront: Many studies on caffeine measure sleep or performance/physiology—but not always anxiety as a primary, validated anxiety outcome. This means that while mechanisms can be inferred plausibly from many findings, you cannot reliably quantify how strongly “anxiety clinically” increases or decreases.

Several papers in your study list point in this direction. The review focused on caffeine-containing brains emphasizes sleep-related EEG effects and mechanistic relationships (Chmiel et al., 2026, PMID 42075032). That helps explain why caffeine might influence sleep architecture—but EEG is not an anxiety-scale value. Anxiety disorders, panic, or general anxiety in daily life are often quantified via questionnaires/scales (e.g., anxiety inventories). In the selection at hand, this direct outcome is not consistently represented as a primary target.

Similarly, the RCTs on caffeine reduction or caffeine/paraxanthin interventions are mostly oriented toward sleep quality, physiology, or performance endpoints. Bingol et al. examined in a randomized crossover design caffeine vs. paraxanthin on rowing performance and sleep quality (Bingol et al., 2026, PMID 41918248). This can be indirectly relevant for anxiety when worse sleep leads to more tension—but anxiety as an outcome is not automatically measured there.

The RCT on dose and timing also primarily looks at “subsequent sleep” effects (Gardiner et al., 2025, PMID 39377163). This is methodologically valuable because timing is a causal lever. But it does not guarantee that you can derive an effect size for anxiety from it.

Additionally, there is a remote-controlled caffeine reduction intervention (Knerr et al., 2026, PMID 41864111). Intervention studies like this are often particularly practice-relevant (behavior change), but whether and how anxiety is measured depends on the study design—in the study descriptions here, the primary focus is on caffeine reduction.

In short: If you want to know “does caffeine really make you more anxious?,” you need studies that measure anxiety validly and quantitatively. In the selection at hand, this kind of evidence for anxiety as the main endpoint is not consistently available. This is not a contradiction to the sleep evidence; it is simply a measurement gap: sleep is a likely pathway, but it is not automatically the same as anxiety as a clinical outcome. If you want mechanistic framing, also look at the debate around the role of sleep and circadian factors (Circadian rhythm: effects & evidence (what is supported)).

Evidence hierarchy: RCTs before reviews—and where anxiety data are thin

If you expect strong statements (“caffeine increases anxiety by X”), the sober answer is: for anxiety as a primary outcome, the evidence in this study selection is limited. The strongest causal evidence comes from RCTs, but these RCTs often measure sleep or physiology rather than anxiety disorders directly.

Why RCTs are still the backbone: Randomized controlled trials reduce systematic bias and support causality more strongly than observational studies. In your list, there are multiple RCTs addressing this causality for sleep or physiological variables. Gardiner et al. investigate dose and timing effects on subsequent sleep (Gardiner et al., 2025, PMID 39377163). Methodologically, this is especially relevant because “evening anxiety” often temporally coincides with “caffeine too late” or “too much.”

The review by Chmiel et al. is useful as a systematic mechanistic framing—but reviews are not automatically “anxiety quantifiers.” It summarizes studies showing sleep EEG and mechanisms (Chmiel et al., 2026, PMID 42075032). From this, plausibility can be inferred, but not the clinical effect size on anxiety disorders in everyday life.

Where the anxiety data are still indirectly compatible: There are RCTs that change caffeine behavior and could therefore influence sleep- and day-to-day outcomes. Knerr et al. evaluates a remote-controlled caffeine reduction intervention (Knerr et al., 2026, PMID 41864111). These studies are exactly the type of intervention that tests whether you can steer caffeine so that unwanted effects are reduced. Whether anxiety is measured and how strongly it is affected is, however, a different question.

For “caffeine/paraxanthin and sleep quality,” Bingol et al. compares effects on performance and sleep quality (Bingol et al., 2026, PMID 41918248). Again: sleep is a plausible mediator, but anxiety is not automatically identical.

Conclusion for the evidence hierarchy:

• RCTs support causality for sleep and time-dependent effect profiles.
• Reviews provide mechanisms/framing, but they are not equivalent to quantitative anxiety outcomes.
• For anxiety as a clinical, quantitative primary goal, the data in the selection at hand are not consistently available.

If you also considered substances like “caffeine + L-theanine,” these may have been studied in an RCT context, but again primarily as a performance/cognition question—not as an anxiety endpoint. Razazan et al. examined exactly this in elite wrestlers (Razazan et al., 2025, PMID 40977612). The data may be interesting, but they do not automatically provide the anxiety quantification.

Evidence overview: Timing, sleep quality, EEG, and interventions

Core answer: The studies in your list most reliably suggest that caffeine can affect sleep and sleep-related physiology (EEG, sleep quality, timing/dose). For anxiety directly as an outcome, the data are less consistent and often not primarily measured.

What does this mean for practice? The robust, well-transferable rule of thumb is: if you notice anxiety (or tension) in the evening, the most likely lever is caffeine timing, because it directly relates to subsequent sleep (Gardiner et al., 2025, PMID 39377163). Methodologically, this is cleaner than “supplement against anxiety,” because it targets the intermediate variable: sleep.

The EEG framing from the review additionally supports that caffeine does not only make people feel subjectively more alert—it can have measurable effects on sleep-related brain activity (Chmiel et al., 2026, PMID 42075032). Even if you cannot map every EEG signal directly to everyday anxiety, it strengthens the hypothesis: worse sleep can promote mood-related shifts the next day.

How does L-theanine fit in? Razazan et al. studied caffeine and L-theanine in elite wrestlers with a focus on cognitive as well as specific physical performance (Razazan et al., 2025, PMID 40977612). This can be interesting if you “need” caffeine. But: that does not automatically translate to how strongly anxiety peaks in everyday life are reduced. That would be a different measurement question.

At the same time, caffeine behavior is changeable. Knerr et al. tests a remote-controlled caffeine reduction intervention (Knerr et al., 2026, PMID 41864111). This is practically relevant because many people do not fail at “in/out,” but at day-to-day management: timing, habits, amount. A behavioral intervention can therefore often help more than the “recipe” for a supplement.

If you want to go deeper into general caffeine mechanics and evidence, you can also find framing in this overview article: Caffeine: effects & evidence—what is supported, what is missing.

Look closely: Dose timing, combinations (e.g., L-theanine), and what you can practically infer

Direct answer: If you tend toward anxiety/tension, the most likely first lever is reducing dose and prioritizing timing, because the best causal evidence in your list targets subsequent sleep (and its time-dependent changes). Combinations like caffeine + L-theanine are possible, but the data address performance/cognition rather than anxiety outcomes.

A practical decision logic could look like this:

1. Protect sleep before you try to fight anxiety. If caffeine later in the evening spills into sleep, “anxiety the next day” as an indirect effect is plausible. Gardiner et al. specifically examine dose and timing effects on subsequent sleep (Gardiner et al., 2025, PMID 39377163). This is the most robust timing foundation in your list.
2. If you need caffeine: consider that it may not only be “caffeine” per se, but also the formulation/metabolism (e.g., paraxanthin) that influences sleep. Bingol et al. compare caffeine with paraxanthin and report effects on performance and sleep quality (Bingol et al., 2026, PMID 41918248). This can explain why some people respond differently to similar amounts.
3. Caffeine + L-theanine as an option—but with limited anxiety inference. Razazan et al. tests caffeine and L-theanine in elite wrestlers focusing on cognitive and specific physical performance (Razazan et al., 2025, PMID 40977612). Combination data like this are interesting if you want to reduce the side effect “too much drive at the cost of rest.” However: transferring this to “everyday anxiety spikes” remains a hypothesis as long as anxiety is not measured cleanly and as a primary outcome.

Important for expectations: Even if the mechanism fits, effects are likely individual. People differ in sensitivity, sleep pressure, circadian phase, and in how accustomed they are to consuming caffeine “earlier” or “too late.”

Regarding “dose and timing,” your list contains RCT evidence for time-dependent sleep effects (Gardiner et al., 2025, PMID 39377163). But a specific universally applicable dose range “for anxiety” cannot be derived responsibly from this study selection, because the studies are not presented as anxiety-specific dose-response curves. Instead, proceed iteratively:

• First adjust timing (caffeine earlier in the day).
• Then reduce amount if evening tension or sleep problems persist.
• In parallel, stabilize sleep routine and daylight exposure (see lifestyle levers above).

If you still think about supplements anyway: the key point remains that supplements often offer fewer “levers” in the evidence gap than timing, light, movement, and sleep routine. This is consistent with the conceptual pathways in your study list: the strongest causality comes via sleep parameters.

Safety & limits: What is especially critical for anxiety/sleep—and what is not proven

Core answer: This study list primarily shows that caffeine can affect sleep. Whether this clinically meaningfully strengthens anxiety disorders in every case is not consistently proven. If you have an anxiety disorder, panic, severe sleep problems, or relevant cardiovascular risks, changing dose/timing without medical guidance is especially risky in practice—because the breadth of evidence for those scenarios is not fully covered.

What you can infer from the cited caffeine-related studies: The RCTs and the mechanistic review focus primarily on sleep/EEG/physiological parameters. The safest conclusion, therefore, is: caffeine can impair sleep; this can indirectly lead to more tension. Causality for anxiety as a clinical symptom, however, remains a measurement gap (Chmiel et al., 2026, PMID 42075032; Gardiner et al., 2025, PMID 39377163; Bingol et al., 2026, PMID 41918248).

What you should NOT infer from this:

• No evidence that caffeine increases anxiety in all people.
• No evidence that caffeine “causes anxiety disorders.”
• No universally applicable dose schemata “against anxiety,” because in your selection, anxiety outcomes are not consistently captured quantitatively as the primary target.

Additionally, it is important: your study list includes pharmacological contexts related to sleep/sedation/anesthesia, but not as caffeine-specific anxiety solutions. Schnider et al. examines effects of a sedating agent (Dexmedetomidine) on sleep in humans (Schnider et al., 2025, PMID 39601561). Narayan et al. examines combined cannabinoid formulations on same-day sedative effects and night-time sleep effects (Narayan et al., 2025, PMID 40542913). These are not caffeine substitutes and are not a basis for deriving “caffeine anxiety.”

On the supplement question at the edge of relevance: Mahadevan et al. studies an Ashwagandha formulation (Zenroot™) and reports improvements in stress- and anxiety-symptoms as well as mood and sleep quality (Mahadevan et al., 2025, PMID 40875185). This is relevant for “anxiety/stress” outcomes in general—however, it is not evidence that it specifically works “against caffeine-related anxiety.” It only shows: in stress/anxiety symptom domains, a particular intervention (Ashwagandha formulation) may help, but it cannot be generalized as a caffeine-specific countermeasure.

Safety boundary in implementation: If you already suffer from severe insomnia or pronounced anxiety, any change to stimulants (caffeine) can shift your symptom curve in the short term. Therefore, dose/timing changes should be closely monitored, and medical support is sensible if you have relevant pre-existing conditions. This study selection does not cover all risk groups completely (this is an evidence limitation, not a blanket “everything is safe” statement).

What to take away

• The best causally supported lever from the evidence is caffeine timing: it influences subsequent sleep (Gardiner et al., 2025, PMID 39377163).
• The biologically plausible mechanisms for sleep changes are supported by sleep-related EEG effects (Chmiel et al., 2026, PMID 42075032).
• “Anxiety from caffeine” is often plausible as an indirect pathway via poor sleep, but robust data with anxiety as a primary, clinically measurable outcome are limited in this selection.
• Lifestyle before supplements: sleep routine, daylight, and movement address the most likely mediator (recovery).
• Combinations like caffeine + L-theanine have been studied (Razazan et al., 2025, PMID 40977612), but they do not replace anxiety-specific outcome data—and therefore remain more of a “functional option” than a guaranteed “anxiety solution.”